Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing 401–420 of 2576 stories
Biopharma IPO activity remains subdued with only six companies going public in January, but a recent SPAC raised $172.5 million, exceeding its initial target of $125 million. This indicates cautious optimism in the sector as more companies prepare to enter the market.
The CDC has launched a series of webinars and podcasts focused on fungal diseases, providing access to clinical resources from leading experts. This initiative aims to enhance awareness and understanding of fungal infections among healthcare professionals.
The CDC has released updated data on confirmed norovirus outbreaks submitted to CaliciNet, detailing state-specific and genotype information. This data is crucial for public health monitoring and response strategies.
The CDC has released new data reports aimed at tracking healthcare-associated infections (HAIs) and identifying areas requiring targeted assistance. This initiative supports ongoing efforts to improve patient safety and healthcare quality.
The CDC has launched new resources aimed at supporting young workers, focusing on health and safety in the workplace. These materials are designed to educate and empower young employees about their rights and responsibilities.
The CDC provides weekly updates on confirmed measles cases in the U.S., highlighting ongoing outbreaks. This information is crucial for public health policy and vaccination strategies.
Mayo Clinic's research demonstrates the effectiveness of CRISPR-based gene editing in targeting the PKD1 gene mutation responsible for polycystic kidney disease. This breakthrough offers a potential shift in treatment, moving beyond merely slowing disease progression to directly correcting the genetic cause.
The proposed rule by HHS aims to enhance the Conditions for Coverage for Organ Procurement Organizations (OPOs), focusing on improving organ procurement and transplantation processes. Key revisions include new Quality Assessment Performance Improvement (QAPI) requirements to better manage medically complex organs and donors.
The ONC has issued a Request for Information to gather public input on potential diagnostic imaging interoperability standards and certification criteria. This initiative aims to enhance the access and exchange of diagnostic images among healthcare providers and patients.
The Administration for Children and Families (ACF) seeks a 3-year extension for the TANF Financial Report (ACF-196T) without substantive changes but aims to streamline instructions, reducing review time by 33%. This update is intended to enhance clarity for stakeholders involved in the TANF program.
The FDA is seeking comments for its upcoming RISE Workshop series aimed at addressing common challenges in rare diseases. This initiative will explore innovative scientific solutions applicable across multiple diseases.
The Department of Health and Human Services is seeking nominations for the Interagency Pain Research Coordinating Committee, aimed at enhancing pain research coordination. This initiative highlights the ongoing efforts to address pain management and research in the healthcare system.
The biopharma industry is experiencing a resurgence with increased M&A activity and rising stock prices, signaling optimism for 2026. However, regulatory challenges and competition from China pose significant risks to this recovery.
A measles outbreak in Colorado linked to an infectious traveler has prompted a public health response. The incident highlights the ongoing need for vigilance in vaccination and disease prevention strategies.
The CDC highlights the need for improved tuberculosis testing protocols following a school-based exposure incident in Lake County, Illinois. This report emphasizes the importance of addressing violence exposure in childhood as a factor in health outcomes.
CERo reports promising early safety data from its phase 1 trial of CER-1236, leading to an expansion of the trial protocol. This development could enhance the therapeutic landscape for patients awaiting new treatment options.
ENA Respiratory has initiated dosing in a Phase 2 study of INNA‑051, a nasal spray aimed at reducing symptomatic viral respiratory infections. The trial will evaluate the efficacy of once-weekly treatment in this indication.
AgomAb Therapeutics, a Belgian biotech focused on TGFβ inhibitors for fibrotic diseases, is set to raise $200 million through its IPO, offering 12.5 million shares priced between $15 and $17. The company is also developing a preclinical candidate for liver cirrhosis.
SpyGlass Pharma sets terms for a $150 million IPO, offering 9.4 million shares priced between $15 and $17. This Phase 3 biotech focuses on developing implants for chronic eye conditions, aiming for a market value of $549 million at the midpoint.
The CDC reports a new recall related to a Salmonella outbreak linked to dietary supplements containing moringa leaf powder, affecting 65 individuals across 28 states. This highlights ongoing safety concerns in dietary supplements and the need for consumer awareness.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.